货号:A523680
同义名:
Galantamine hydrobromide; Galanthamine hydrobromide
Galanthamine HBr 是一种天然 AchE 抑制剂(IC50 410 nM),作为神经元 nAchRs 的变构增强剂,常用于轻度至中度阿尔茨海默病及记忆障碍的研究。
HazMat Fee + There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
| Type | HazMat fee for 500 gram (Estimated) |
| Excepted Quantity | USD 0.00 |
| Limited Quantity | USD 15-60 |
| Inaccessible (Haz class 6.1), Domestic | USD 80+ |
| Inaccessible (Haz class 6.1), International | USD 150+ |
| Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
| Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 靶点 |
|
| 描述 | Galanthamine Hydrobromide is acetylcholinesterase inhibitor (AChEI) and a neuroactive drug capable of passing through the blood–brain barrier and can slow down the effects of AD[3]. Incubation of the cells for 48 h with 300 nM galantamine doubled the density of α7 nicotinic receptors and tripled the expression of the antiapoptotic protein Bcl-2[4]. Moreover, pretreatment with galantamine (8 mg/kg, i.m.) prevented the reduction of EPSC (excitatory postsynaptic currents) frequency observed at 6-9 days after the soman challenge[5]. |
| Concentration | Treated Time | Description | References | |
| HT-22 cells | 10 μM | 24 hours | To investigate the effect of galantamine on Mi-sup-induced inflammatory response in HT-22 cells. Galantamine reduced the Mi-sup-induced increase in NF-κB p65 levels and expression of pro-inflammatory cytokines (IL-1β and IL-6). | J Neuroinflammation. 2018 Apr 18;15(1):112 |
| BV-2 cells | 10 μM | 24 hours | To investigate the effect of galantamine on LPS-induced inflammatory response in BV-2 cells. Galantamine reduced the LPS-induced increase in NF-κB p65 levels. | J Neuroinflammation. 2018 Apr 18;15(1):112 |
| α7 nACh receptors stably expressed in HEK293 cells | 10 nM to 10 μM | 40 s pre-application (60 s for 0.01 μM), followed by 250 ms co-application with ACh | To validate modulatory effects of galanthamine on α7 nACh receptors in HEK293 cells. Results aligned with oocyte experiments, showing no positive modulation and inhibition at high concentrations (100 μM). | Br J Pharmacol. 2018 Jul;175(14):2911-2925 |
| RAW 264.7 cells | 10 μmol/L | 24 hours | To investigate the effect of Galanthamine on LPS-induced migration of RAW 264.7 cells, results showed that Galanthamine significantly inhibited LPS-induced cell migration. | Acta Pharm Sin B. 2020 Oct;10(10):1926-1942 |
| Administration | Dosage | Frequency | Description | References | ||
| Kunming mice | LPS-induced neuroinflammation model | Intraperitoneal injection | 4 mg/kg | Once daily for 14 days | To investigate the effect of galantamine on LPS-induced cognitive impairment and neuroinflammation. Galantamine improved LPS-induced deficits in spatial learning and memory, reduced the expression of CD11b, GFAP, NF-κB p65, and pro-inflammatory cytokines in the hippocampus, and increased the levels of synapse-associated proteins (SYN and PSD-95). | J Neuroinflammation. 2018 Apr 18;15(1):112 |
| Wistar rats | Adolescent intermittent ethanol (AIE) exposure model | Intraperitoneal injection | 4 mg/kg | In the prevention study, administered 30 min prior to each gavage, totaling 16 doses; in the restoration study, administered daily for 2 weeks starting from P57 | Galanthamine prevented and reversed AIE-induced neuroimmune signaling and loss of hippocampal neurogenesis. In the prevention study, galantamine pretreatment blocked AIE induction of CCL2, HMGB1, and COX-2, and prevented the reduction in neurogenesis. In the restoration study, galantamine treatment reversed AIE induction of these inflammatory markers and restored neurogenesis. | J Neuroinflammation. 2021 Sep 16;18(1):212 |
| Mice | Caerulein-induced acute pancreatitis model | Intraperitoneal injection | 1, 4, or 6 mg/kg body weight | Administered once 1 hour before the first caerulein injection and again 30 minutes after the third injection | Galanthamine significantly attenuated pancreatic histologic injury, reflected by a reduction in serum amylase and pancreatic inflammatory cytokines and an increase in the anti-inflammatory cytokine IL-10 in the serum. These beneficial effects were not altered by bilateral subdiaphragmatic vagotomy, knockout of either choline acetyltransferase-positive T cells or α7nAChR, or administration of the nAChR ganglionic blocker mecamylamine or the more selective α7nAChR antagonist methyllycaconitine. | Mol Med. 2023 Oct 31;29(1):149 |
| Mice | Opa1–/– mice and aged WT mice | Oral | 3.28 mg/kg bodyweight/d | Daily for 90 days (Opa1–/– mice) or 18 weeks (aged mice) | RJx-01 (containing Galanthamine) improved muscle function, reduced denervation, decreased inflammatory markers, ameliorated mitochondrial morphology and autophagy, and increased satellite cell content. | JCI Insight. 2023 Aug 8;8(15):e168787 |
| Mice | FMF-KI mice (MefvV726A/V726A) | Intraperitoneal injection | 4-12 mg/kg (escalated by 4 mg every 2 weeks) | Twice daily for 8 weeks | To assess the impact of long-term Galanthamine on chronic inflammation in FMF-KI mice. Results demonstrated significant attenuation of splenomegaly, reduced inflammatory cell infiltration (e.g., spleen and subcutaneous air pouch), decreased serum amyloid A (SAA) levels, and improved anemia. Notably, Galanthamine's effects persisted in vagotomized or α7nAChR-KO mice, suggesting a mechanism independent of the classical cholinergic anti-inflammatory pathway. | Mol Med. 2022 Dec 9;28(1):148 |
| Sprague-Dawley rats | Cardiac ischemia/reperfusion (I/R) model | Isolated heart perfusion | 5 × 10^-8 M | 30 min ischemia followed by 40 min reperfusion | To investigate the effect of galantamine on cardiac ischemia/reperfusion injury in isolated hearts. Results showed that galantamine treatment significantly improved left ventricular function (LVDP, ±dP/dt, WP) without affecting heart rate. | Mol Med. 2017 Jul;23:120-133 |
| Male adult Wistar rats | Experimental model of dementia induced by scopolamine | Intraperitoneal injection | 1 mg/kg | For 9 consecutive days | To evaluate the neuroprotective effects of galantamine in scopolamine-induced dementia in rats. Results showed that galantamine significantly increased brain ACh levels, improved recognition memory and habituation, and restored the cholinergic system influence index. | Antioxidants (Basel). 2022 Feb 12;11(2):374 |
| NOD mice | Type 1 diabetes model | Intraperitoneal injection | 1 mg/kg | Daily for 20 weeks | To study the preventive effects of galantamine in type 1 diabetes, results showed that galantamine significantly delayed the onset of hyperglycemia, reduced pancreatic islet inflammation, and decreased serum levels of anti-insulin antibodies. | Mol Med. 2015 Nov;21(1):702-708 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.72mL 0.54mL 0.27mL |
13.58mL 2.72mL 1.36mL |
27.15mL 5.43mL 2.72mL |
|
| CAS号 | 1953-04-4 |
| 分子式 | C17H22BrNO3 |
| 分子量 | 368.27 |
| SMILES Code | O[C@H]1C=C[C@@]23CCN(C)CC4=CC=C(OC)C(O[C@@]3([H])C1)=C24.Br |
| MDL No. | MFCD00067672 |
| 别名 | Galantamine hydrobromide; Galanthamine hydrobromide; NSC 100058; Galanthamine; Galantamine (hydrobromide) |
| 运输 | 蓝冰 |
| InChI Key | QORVDGQLPPAFRS-XPSHAMGMSA-N |
| Pubchem ID | 121587 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, store in freezer, under -20°C |
| 溶解方案 |
DMSO: 12 mg/mL(32.59 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 15 mg/mL(40.73 mM),配合低频超声,并水浴加热至45℃助溶 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1